Allergies
Arthritis
Arthritis and Acupuncture
Arthritis and Gene Therapy
Therapy and Bone Repair
About Arthritis
Osteoarthritis
Rheumatoid Arthritis
Automimmune diseases
Autoimmune Diseases
About Autoimmune Diseases
Lupus Chinese Medicines
Lupus Treatments
Thrush primary immunodeficiency
Thrush
Bladder problems
Transurethral Resection
About Bladder Problems
Overactive Bladder
Treating Overactive Bladder
Urinary Incontinence Causes
Urinary Incontinence
Urinary Tract Infections and Diet
Urinary Tract Infections
Blood and vascular disorders
Warfarin and Vitamin K
About Blood and Vascular Disorders
Varicose Veins Risks
Varicose Veins
Waldenstroms
Cancer
HRT and Breast Cancer
Research and Breast Cancer
Food Prevention
About Cancer
Kidney Cancer
Kidney Tumors
Leiomyosarcoma
Leukemia Survival
Leukemia
Liver Cancer
Lung Cancer New Treatments
Lung Cancer
Lymphoma Actually Two Forms of Cancer
Lymphoma
Milk Treatment
Mouth Cancer
Oral Cancer Treatment
Ovarian Cancer
Ovarian Cancers Gene Mutations
Pancreatic Cancer Protein Tumor Fighter
Pancreatic Cancer
Prostate Cancer Treatment
Prostate Cancer
Testicular Cancer Transplants
Testicular Cancer
Throat Cancer Your Voice
Throat Cancer
Uterine Cancer Detection
Uterine Cancer
Cholesterol
Diabetes
Diabetes in Children
Diabetes Insipidus
Diabetes Risk
Diabetic Retinopathy
About Diabetes
Peripheral Neuropathy
Type 1 Diabetes
Type 1 Treatment
Type 2 Diabetes
Type 2 Treatment
Erectile dysfunction
Headaches
Heart problems
Heartburn and gerd
Herpes
Hypertension
Causes and Symptoms
Fighting Hypertension
Angiostensin II Blockers
Hypertension Medications
Hypertension-Headaches
About Hypertension
Preventing Hypertension
Intestinal problems
Crohn's Disease
Lung diseases
Obesity
Osteoporosis
Pain
Hormone Therapy
About Intestinal Problems
Irritable Bowel Syndrome
Ulcerative Colitis Self Management
Ulcerative Colitis
About Pain
New Class of Anti-Inflammatory Painkiller
Nervous System
Pain Management Cycles
Pain Management evaluation
Prostate problems
Psychiatric disorders
Alcohol and Dementia
New Molecule to Reduce Amyloid Depostis
Screening Tools for Alzheimers
Blood Flow and Alzheimers
Alzheimer's and Caregivers
Anemia & Dementia
Anxiety and Perception
Child Abuse and Depression
Anxiety and the Adolescent
Coping with Depression
The Elderly
About Psychiatric Disorders
Parkinsons Disease Dopamine
Parkinson's Disease
Teen Health & Depression
Teenage Depression
Salivary glands
Skin disorders
Acne Causes
Laser Treatments for Acne
About Skin Disorders
Psoriasis Treatment
Psoriasis
Rosacea Symptoms
rosacea
Skin Cancer Survival
Skin Cancer
Treatment Options
Sleep
Drugs Sleep Deprivation
About Sleep
Insomnia and Alcohol
Insomnia and Tea
Insomnia
Sleep Disorders Narcolepsy
Sleep Disorders
Students Sleep Deprivation
Turner syndrome
Wellness
Womens health
Reluctance to Seek Help for FSD
About Womens Health
Intranasal Apomorphine HCl
Menopause Symptom Relief
Uterine Fibroids Treatment
Uterine Fibroids
|
Methotrexate: Holding the Line Against Crohn’s DiseaseWhile medical researchers work to find the cause and develop new treatments for inflammatory bowel disorders such as Crohn’s disease, they are also focusing recent efforts on medications currently in use that might provide prolonged remission of symptoms. Although identifying a cure is the ultimate goal, being able to reduce symptoms, both in severity and in frequency, is as important to individuals currently afflicted with these conditions.Methotrexate, a medication used successfully in patients diagnosed with certain types of rapidly growing cancers, rheumatoid arthritis and severe psoriasis, has been identified as a means to bring about remission in those individuals suffering from bowel disorders. In a recent study, this hypothesis was tested to see whether, after an initial course of drug therapy, a low dose of the drug might prevent the recurrence of Crohn's disease symptoms. Dr. Brian G. Feagan, and other members of the North American Crohn’s Study Group Investigators, conducted a forty-week observation of two groups of patients who were in remission after being treated over a period of 16 to 24 weeks with low doses of methotrexate. Individuals were selected at random, with one group of 40 participants receiving low doses of methotrexate and the other group of 36 participants receiving placebos. Feagan’s group believed that the level of recurrence would be significantly less in patients who continued to receive the low dose of methotrexate. This theory was borne out by the end results: remission continued for 65 percent of the test group as compared to 39 percent in the control group. Those patients who did have relapses received the drug prednisone. Here, too, the test group fared better: a 28 percent relapse occurred among those who had taken methotrexate, compared with a 58 percent relapse among those who had taken the placebo. Lastly, 22 of the 36 participants who suffered a relapse during the study were given a slightly higher dose of methotrexate: 55 percent went into remission by the end of the forty weeks. Fegan's results confirm those of an earlier study by the same group on the efficacy of low dose methotrexate in the treatment of Crohn's. The earlier sixteen-week study evaluated 141 people: 39 percent of the 94 participants receiving methotrexate remained in remission as compared to 19 percent the 47 participants taking the placebo. This research established that the use of methotrexate might well be a long-term source of remission for people with Crohn’s or similar conditions. This is not to say, however, that it is a remedy for everyone. Issues concerning the potential increase of liver disease are still not resolved and will definitely require further study. Other issues, such as the drug’s contraindication for use in women of childbearing age, must also be addressed. Overall, however, these studies showed that long-term remission is possible. Until a cure is found, this finding is a major step in improving the quality of life for persons afflicted with Crohn's disease. Resources Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., Hanauer, S.B., McDonald, J. W. D. (2000, June 1). A comparison of Methotrexate with placebo for the maintenance of remission in Crohn’s disease. The New England Journal of Medicine, Vol. 342, No. 22:1527-1632. Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, Gillies, R., Hopkins, M., Hanauer, S.B., McDonald, J. W. D. (1995, February 2). Methotrexate for the treatment of Crohn’s disease. The New England Journal of Medicine, Vol. 332, No. 5:292-297. Teasdale, C. (2000, June 20). Chemo agent may also aid Crohn's disease patients. The Medical Post, Vol. 36, No. 23. Retrieved August 18, 2002, from http://www.medicalpost.com/mdlink/english/members/ medpost/data/3623/02C.htm. |
Ads by Yahoo!
Crohn's Disease Symptoms
Take The Quiz. Learn & Control Your Crohn's Disease Symptoms. www.LivingWithCrohnsDisease.com Crohn's Disease Learn About Crohn's Disease Now- Symptoms, Treatments and More. www.crohnsonline.com Symptom of Chrons Disease Helping Crohns. Guaranteed Since 1996 Get relief BBB Rated ampfloracel.com/crohns |
|
Home
| About Us
| Terms of Use
| Privacy & Security
| Site Map
| © morefocus group, inc. | |
